Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved heterotrimeric enzyme complex that serves as the central sensor of cellular energy status across all eukaryotic species (Hardie, 2014 [4]). It is activated in response to energy stress, signaled by rising ratios of AMP:ATP or ADP:ATP, which occur during nutrient deprivation, hypoxia, or physical exertion (Winder & Thomson, 2007 [2]). Upon activation, AMPK restores metabolic homeostasis by stimulating catabolic pathways that produce ATP, such as glucose uptake and fatty acid oxidation, while simultaneously inhibiting anabolic pathways that consume ATP, including the synthesis of fatty acids, cholesterol, and proteins (Inoki et al., 2012 [6]). This 'master switch' function makes AMPK a primary therapeutic target for metabolic disorders like type 2 diabetes and obesity, where its activation improves glucose sensitivity and lipid profiles (Inoki et al., 2012 [6]). Furthermore, AMPK is an area of intense research in oncology and neurodegeneration due to its ability to modulate cell growth, autophagy, and mitochondrial health (Hardie, 2014 [4]; [13]).
AMPK is activated by an increase in the cellular AMP:ATP ratio, leading to the phosphorylation of downstream targets such as ACC (Acetyl-CoA carboxylase) and TBC1D1, which promotes ATP-generating catabolic processes and inhibits ATP-consuming anabolic processes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-adenosine monophosphate-activated protein kinase (AMPK) (AMPK).